NCAPG

Across TCGA pan-cancer cohorts, NCAPG RNA differs between tumor and matched normal tissue in 17 of 18 cancer types tested, making tumor–normal expression one of NCAPG’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NCAPG RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NCAPG is over-expressed in tumor.

HNSC, LUAD, and BLCA are the cancer types where NCAPG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NCAPG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+1.839	<.001	12	view →
LUAD	All	IV	+3.415	<.001	11	view →
BLCA	Male	III,IV	+2.944	<.001	11	view →
KIRP	All	III,IV	+1.694	<.001	11	view →
KIRC	Male	IV	+1.499	<.001	11	view →
STAD	Female	All	+2.581	<.001	9	view →
LIHC	Male	All	+2.067	<.001	9	view →
COAD	Female	II,III,IV	+1.322	<.001	9	view →
LUSC	Female	II,III,IV	+3.392	<.001	8	view →
UCEC	All	III,IV	+3.314	<.001	8	view →
BRCA	All	III,IV	+2.329	<.001	6	view →
KICH	All	All	+0.709	.015	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 17 lineages.

NCAPG–HNSC

Open the HNSC breakdown →